Gynecology & Obstetrics in New York

FEMSelect Inc. is a women's health medical device company headquartered in Newark, Delaware, with international operations in Israel, Chile, Costa Rica, Cyprus, and Mexico. The company develops and commercializes minimally invasive medical devices for the treatment of pelvic organ prolapse (POP), a condition affecting more than half of women over 50. The primary product is EnPlace, an FDA-cleared same-day, minimally invasive surgical approach for pelvic organ prolapse that typically requires no overnight hospital stay and aims to enable women to return quickly to normal activities including exercise and intimacy. The company also offers Elitone, a related pelvic health product. EnPlace is positioned as an alternative to conservative management approaches such as pessaries, physical therapy, and Kegel exercises, as well as to traditional surgical interventions. FEMSelect operates a network of trained providers across the United States and internationally through regional distribution partners. The company maintains FDA regulatory clearance for its products and serves gynecologists, urologists, urogynecologists, and other clinicians who manage pelvic floor disorders. Manufacturing and clinical trial data demonstrate human efficacy and safety. The company focuses on patient education and provider training to expand access to minimally invasive pelvic organ prolapse treatment.

Fine Surgical Instruments, Inc. is a leading manufacturer and distributor of precision surgical instruments based in Hempstead, New York. The company supplies the global medical industry with an extensive range of high-quality surgical instruments across multiple specialties. Their comprehensive product portfolio includes diagnostic instruments, scalpels, scissors, forceps, needle holders, retractors, suturing instruments, and specialty tools for ophthalmology, ENT, gynecology, obstetrics, orthopedics, cardiology, urology, thoracic, neurosurgery, and bariatric procedures. Fine Surgical serves hospitals, surgical centers, and medical practitioners worldwide, offering both standard surgical instruments and specialized equipment for various surgical disciplines. The company provides an online catalog for procurement efficiency and maintains dedicated domestic and international sales teams.

Founded in 1978, Skil-Care Corporation is a women-owned small business (WBENC-certified) specializing in the design and manufacturing of safety, comfort, and mobility healthcare products for nursing homes, hospitals, rehabilitation facilities, and homecare settings. The company's comprehensive product portfolio addresses fall prevention, wound management, pressure relief, patient positioning, and mobility assistance. Key offerings include positioning wedges, heel/elbow protectors, gait belts, mattresses, cushions, wheelchair accessories, bariatric products, incontinence supplies, bed rail pads, safety alarm systems (including the proprietary SignalSafe Fall Monitor), and recreation/exercise equipment. Skil-Care serves clinicians, facility administrators, and families with evidence-based products designed to enhance patient safety and comfort while reducing caregiver burden in clinical and home settings.

TMRW Life Sciences manufactures and operates the world's first FDA-cleared automated platform for specimen management and cryogenic storage of frozen eggs and embryos. The company serves fertility clinics with an integrated digital ecosystem comprising RFID-tracked inventory management, ivfOS software database, 24/7 monitoring via Overwatch®, and flexible storage configurations (onsite/offsite, liquid/vapor phase nitrogen). TMRW's core offering includes automated storage systems (robots and vault solutions), specimen transport with GPS tracking, digital chain-of-custody documentation, and a biorepository service for patients. The platform is designed by embryologists and addresses legacy dewar-based specimen management by consolidating inventory control, reducing operational footprint, and minimizing points of failure by up to 94%. Regulatory credentials include FDA clearance, CE marking, and HIPAA-compliant data security. Target market is fertility clinics ranging from single-site practices to multi-clinic networks. The company emphasizes reduced cryoroom footprint, digitized legacy inventory systems, and real-time specimen visibility. Services include clinic support, patient biorepository options, and ongoing platform monitoring.

Ackermann Instrumente GmbH is a German manufacturer of precision surgical instruments, endoscopic systems, and minimally invasive surgery devices with over 70 years of industry experience. The company specializes in reusable hand instruments, rigid and flexible endoscopes, hybrid instruments, and complete endoscopy tower systems serving arthroscopy, laparoscopy, gynecology, urology, and ENT specialties. Product portfolio includes over 8,000 SKUs: arthroscopy instruments for small joint, shoulder, knee, and hip surgery with unique arthroscopic suturing and ACL/PCL reconstruction solutions; laparoscopic specialty instruments including XPress Lock™ Mini Lap line; comprehensive gynecological instrumentation for hysteroscopic and laparoscopic procedures; urology endoscopy sets featuring bipolar and laser resectoscopy; and ligature solutions including haemostatic titanium and polymer clips with appliers. Flagship visualization products include the NeoLite™ 4K UHD line with backside-illuminated CMOS sensors and Fusion ICG™ 4K UHD line with dual-sensor fluorescence technology. The company maintains ISO 13485:2016, US FDA, CFDA, ANVISA, and COFEPRIS certifications and operates expanded manufacturing facilities in Germany dedicated to instrument assembly. Comprehensive after-sales support includes product training, maintenance, repair, spare parts, warranty, and product return services. In-house R&D capabilities span device development through production.

EQUASHIELD LLC is a global medical device manufacturer specializing in closed-system transfer devices (CSTDs) and pharmacy automation solutions for safe handling of hazardous drugs. Founded in 2009 and headquartered in Port Washington, New York, the company serves hospitals, pharmacies, oncology centers, and cell/gene therapy facilities across more than 25 countries. EQUASHIELD is recognized as the #1 CSTD in U.S. pharmacies for seven consecutive years. The company offers a comprehensive portfolio including manual CSTD products for preparation and administration, automated compounding platforms (Mundus HD for general oncology, Mundus Neo for neonatal/pediatric precision dosing), and CellShield solutions for cell/gene therapy manufacturing. All products are CE-marked and FDA-cleared, supported by clinical evidence. EQUASHIELD emphasizes worker protection, contamination prevention, and dosing accuracy through proprietary pressure equalization technology. The company provides 24/7 clinical support, comprehensive training via EQ Academy, and full process traceability with EMR integration capabilities.

LSI Solutions, Inc. is a medical device manufacturer specializing in innovative surgical instruments and suturing solutions for minimally invasive and open surgical procedures. The company develops proprietary devices for cardiac, general, gynecological, and urological surgery, with particular expertise in mitral valve repair and aortic valve replacement procedures. Their product portfolio includes the RAM (Rapid Annular Materialization) device—an automated titanium fastener system for annular suturing—and related instruments designed to enhance surgical precision, reduce operative time, and improve patient outcomes. LSI Solutions markets and distributes through a global network spanning North America, Europe, Asia-Pacific, the Middle East, and Latin America. The company maintains its global headquarters in Victor, New York, and demonstrates active engagement in surgical innovation through conference participation (AATS 2026, Re-Evolution Summit) and peer-reviewed research publications. Their device portfolio is positioned for cardiac surgeons performing endoscopic and minimally invasive procedures, with clinical evidence supporting safety, efficacy, and reduced complication rates (including lower infective endocarditis risk compared to hand-knot suturing). The company offers 24-hour technical support and maintains regulatory compliance appropriate for US medical device distribution.

Golnit Ltd is a Ukrainian manufacturer of surgical sutures established in 1987, specializing in both absorbable and non-absorbable suture products with premium sharp needles. The company manufactures surgical sutures conforming to U.S.P. (United States Pharmacopeia) and E.P. (European Pharmacopeia) standards in an ISO 7 cleanroom facility. Golnit was the first Ukrainian suture manufacturer and the first in Ukraine to produce synthetic absorbable sutures including PGA, Polyglactin 910, Poliglecaprone 25, and Polydioxanone. Product lines include cardiovascular sutures (PTFE, polyester, polypropylene, PVDF), ophthalmic sutures (polyester, silk, nylon mono, PGA), trauma sutures (stainless steel, polyester, PVDF, nylon mono, polypropylene), obstetrics and gynecology sutures (PGA, PGLA, PGLA Rapid, polydioxanone), dental sutures (including PTFE sutures for implant and periodontal surgery), and abdominal surgery sutures (silk, braided nylon, PGA). Needles are manufactured from high-grade AISI 302 stainless steel. The company offers customization services to meet specific suture-needle combinations and maintains efficient manufacturing with typical delivery within 30 days. Distribution includes direct online sales and U.S. dental clinic sales through NET32's marketplace.

Multisorb Technologies is a global leader in active packaging technology and desiccant solutions, founded in 1961 in Buffalo, New York. The company specializes in protecting products from moisture and oxygen damage through innovative sorbent solutions. With approximately 500 employees, Multisorb operates manufacturing plants in West Seneca and Cheektowaga, New York, as well as in Hyderabad, India. The company offers a diverse range of sorbent products, including desiccants, moisture regulators, oxygen absorbers, and specialty sorbent products. Multisorb provides full-service support, including product development, simulation testing, and equipment design. With over 1,280 clients across pharmaceutical, food, nutraceuticals, cannabis, and other critical industries, Multisorb has established itself as a trusted provider of comprehensive packaging protection solutions.

Plymouth Medical is a Brooklyn-based orthobiologics and regenerative medicine company specializing in evidence-based products and services for healthcare providers across orthopedics, sports medicine, pain management, dermatology, plastics, regenerative esthetics, urology, and OBGYN. The company offers a comprehensive portfolio including platelet-rich plasma (PRP) systems, microfat grafting devices, analgesia systems, hemocytometers, wireless ultrasound probes, and microneedling devices. Beyond product distribution, Plymouth Medical provides clinical staff training, quality control services through PRP analysis and characterization (PAC), patient outcome tracking via the DataBiologics registry, and post-treatment rehabilitation support through digital remote therapeutic monitoring platforms. The company operates with a small core team supported by independent sales representatives across North America, emphasizing ethical guidelines and evidence-based practice in regenerative and orthobiologic treatments.

OsseoPure is a clinical support ecosystem specializing in implant dentistry for dental practices across the United States. The company offers a complete implant system (OsseoPure Fast Fit System) addressing single-unit crowns, FP1/FP2/FP3 bridges, and full-arch rehabilitation cases. Core offerings include: advanced implant designs with bioactive surface technology and progressive thread geometry; Zantex™, a hybrid fixed restoration material offering lightweight comfort and superior strength compared to zirconia; digital workflow integration (scan-design-print/mill-deliver) compatible with major scanning systems; PRF (Platelet-Rich Fibrin) biologic protocols for accelerated soft-tissue healing, bone grafting enhancement, and facial esthetics; comprehensive hands-on CE training courses (24 CE credits) spanning surgical planning, restorative design, chairside education, and laboratory fabrication. Services include remote clinical support from experienced dental professionals pre-, during, and post-procedure. The company is advancing a novel implant system currently under FDA review.

CleftAlign, Inc. is a medical device manufacturer specializing in Presurgical Infant Orthopedics (PSIO) therapy for neonates with cleft lip and palate. The company develops and markets innovative presurgical approximation devices and tapes designed to reduce surgical complexity and improve patient outcomes. NoseAlign® is a patent-pending presurgical cleft nose approximation device that simplifies PSIO therapy through a user-friendly, non-invasive approach requiring no dental impressions or laboratory fabrication. The upcoming LipAlign™ product line extends the company's offerings with presurgical cleft lip approximation tapes. CleftAlign's PLANA (Presurgical Lip, Alveolus, and Nose Approximation) therapy protocol addresses limitations of conventional PSIO methods by reducing office visits (4-5 vs. traditional 8+ visits), shortening therapy duration to 11-12 weeks, eliminating intraoral complications, and avoiding the mega nostril risk associated with older techniques. The devices support early soft tissue remodeling by leveraging neonatal plasticity within the first two weeks post-birth, enabling universal application across unilateral and bilateral cleft presentations (complete and incomplete). NoseAlign® operates through simple, caregiver-friendly application with standard medical adhesive tapes and orthodontic elastics, supervised by qualified cleft teams.